Executive Summary of the Workshop on the Border of Viability-Reference-Cited by-同舟云学术

Executive Summary of the Workshop on the Border of Viability

Published:2005-05-01 Issue:5 Volume:115 Page:1392-1396
ISSN:0031-4005
Container-title:Pediatrics
language:en
Short-container-title:

Author:

Higgins Rosemary D.¹,Delivoria-Papadopoulos Maria²,Raju Tonse N.K.¹

Affiliation:

1. Pregnancy and Perinatology Branch, Center for Developmental Biology and Perinatal Medicine, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland

2. Department of Pediatrics, St Christopher's Hospital for Children, Drexel University College of Medicine, Philadelphia, Pennsylvania

Abstract

One of the most complex areas in perinatal-neonatal medicine remains the care of the mother delivering a newborn infant at the border of viability, referred to as “periviable” gestation. To address the knowledge gaps that preclude optimal, evidence-based care in this critical field of perinatal medicine, the National Institute of Child Health and Human Development organized a workshop in March 2004. This article provides a summary of the discussions, focusing on major knowledge gaps and prioritized suggestions for studies in this area.

Publisher

American Academy of Pediatrics (AAP)

Subject

Pediatrics, Perinatology and Child Health

Link

https://publications.aap.org/pediatrics/article-pdf/115/5/1392/1028955/zpe00505001392.pdf

Reference7 articles.

1. MacDonald H, American Academy of Pediatrics, Committee on the Fetus and the Newborn. Perinatal care at the threshold of viability. Pediatrics. 2002;110:1024–1027

2. Lemons JA, Bauer CR, Oh W, et al. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1995 through December 1996. Pediatrics. 2001;107(1). Available at: www.pediatrics.org/cgi/content/full/107/1/e1

3. NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes. Effects of corticosteroids for fetal maturation on perinatal outcomes. JAMA. 1995;273:413–418

4. Mercer BM, Miodovnik M, Thurnau GR, et al. Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes: National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. JAMA. 1997;278:989–995

5. Ment LR, Oh W, Ehrenkranz RA, et al. Low dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial. Pediatrics. 1994;93:543–550

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Periviable Birth: Between Ethical and Legal Frameworks;The Journal of Pediatrics;2024-09

2. Outcome prediction in newborn infants: Past, present, and future;Seminars in Perinatology;2022-11

3. Developing a resiliency model for survival without major morbidity in preterm infants;Journal of Perinatology;2022-10-11

4. Active Treatment of Infants Born at 22-25 Weeks of Gestation in California, 2011-2018;The Journal of Pediatrics;2022-10

5. A data-driven health index for neonatal morbidities;iScience;2022-04